HK1017356A1 - Process for synthesizing carbapenem antibiotics - Google Patents

Process for synthesizing carbapenem antibiotics

Info

Publication number
HK1017356A1
HK1017356A1 HK99102483A HK99102483A HK1017356A1 HK 1017356 A1 HK1017356 A1 HK 1017356A1 HK 99102483 A HK99102483 A HK 99102483A HK 99102483 A HK99102483 A HK 99102483A HK 1017356 A1 HK1017356 A1 HK 1017356A1
Authority
HK
Hong Kong
Prior art keywords
carbapenem antibiotics
synthesizing carbapenem
synthesizing
antibiotics
carbapenem
Prior art date
Application number
HK99102483A
Other languages
English (en)
Inventor
John M Williams
Ronald B Jobson
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617417.2A external-priority patent/GB9617417D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HK1017356A1 publication Critical patent/HK1017356A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
HK99102483A 1996-07-12 1999-06-08 Process for synthesizing carbapenem antibiotics HK1017356A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2164996P 1996-07-12 1996-07-12
GBGB9617417.2A GB9617417D0 (en) 1996-08-20 1996-08-20 Process for synthesizing carbapenem antibodies
PCT/US1997/011844 WO1998002439A1 (en) 1996-07-12 1997-07-08 Process for synthesizing carbapenem antibiotics

Publications (1)

Publication Number Publication Date
HK1017356A1 true HK1017356A1 (en) 1999-11-19

Family

ID=26309896

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102483A HK1017356A1 (en) 1996-07-12 1999-06-08 Process for synthesizing carbapenem antibiotics

Country Status (18)

Country Link
EP (1) EP0912576B1 (da)
CN (1) CN1085210C (da)
AR (1) AR008255A1 (da)
AT (1) ATE210664T1 (da)
AU (1) AU3720997A (da)
BR (1) BR9710360A (da)
CY (1) CY2310B1 (da)
CZ (1) CZ9199A3 (da)
DE (1) DE69709113T2 (da)
DK (1) DK0912576T3 (da)
EA (1) EA001152B1 (da)
ES (1) ES2167762T3 (da)
HK (1) HK1017356A1 (da)
PT (1) PT912576E (da)
SK (1) SK283298B6 (da)
TW (1) TW513430B (da)
UA (1) UA54444C2 (da)
WO (1) WO1998002439A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7538212B2 (en) * 2002-11-13 2009-05-26 Kaneka Corporation Intermediate for carbapenem compound for oral administration and process for producing the same
EP1926732B1 (en) 2005-09-05 2013-11-06 Ranbaxy Laboratories Limited A process for the preparation of carbapenem compounds
CN101357920B (zh) * 2007-06-22 2011-01-12 山东轩竹医药科技有限公司 含有巯基吡咯烷甲酰胺基三嗪的培南化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101367806B (zh) * 2007-06-28 2010-11-17 山东轩竹医药科技有限公司 甲酰苯胺取代的巯基吡咯烷碳青霉烯类化合物
CN101343272B (zh) * 2007-07-13 2011-02-09 山东轩竹医药科技有限公司 含有环己烷的碳青霉烯化合物
CN101362757A (zh) * 2007-08-09 2009-02-11 山东轩竹医药科技有限公司 磺酰基取代的碳青霉烯类化合物
CN101362763B (zh) * 2007-08-12 2011-01-12 山东轩竹医药科技有限公司 含有巯基吡咯烷的碳青霉烯衍生物
CN101412719B (zh) * 2007-08-30 2010-11-17 山东轩竹医药科技有限公司 碳代青霉烯类衍生物
US8097719B2 (en) * 2008-07-15 2012-01-17 Genesen Labs Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem
CN101875665B (zh) 2009-04-30 2013-02-06 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南中间体、含其的组合物及其制备方法
CN102260264A (zh) * 2010-05-25 2011-11-30 浙江海翔药业股份有限公司 一种非钯体系制备厄他培南的方法
JP2015533142A (ja) 2012-10-12 2015-11-19 サンド・アクチエンゲゼルシヤフト エルタペネム中間体の製造
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds

Also Published As

Publication number Publication date
SK3299A3 (en) 1999-07-12
UA54444C2 (uk) 2003-03-17
ATE210664T1 (de) 2001-12-15
EA199900099A1 (ru) 1999-06-24
AU3720997A (en) 1998-02-09
TW513430B (en) 2002-12-11
SK283298B6 (sk) 2003-05-02
EA001152B1 (ru) 2000-10-30
CZ9199A3 (cs) 1999-06-16
EP0912576B1 (en) 2001-12-12
PT912576E (pt) 2002-05-31
CY2310B1 (en) 2003-11-14
DK0912576T3 (da) 2002-03-25
DE69709113D1 (de) 2002-01-24
CN1085210C (zh) 2002-05-22
CN1225636A (zh) 1999-08-11
BR9710360A (pt) 1999-08-17
DE69709113T2 (de) 2002-07-11
AR008255A1 (es) 1999-12-29
ES2167762T3 (es) 2002-05-16
EP0912576A1 (en) 1999-05-06
WO1998002439A1 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
HUP9603179A3 (en) Process for producing benzyl-ethers
HU9700140D0 (en) Process for producing 0-demethyl-tramadol-enantiomeres
HK1017356A1 (en) Process for synthesizing carbapenem antibiotics
HUP9700380A2 (en) Process for producing 4-oxoimidazolinium-salts
HU9700212D0 (en) Process for producing alkyl-chlorides
HUP9904325A3 (en) Process for johexol manufacture
HUP0003203A3 (en) Process for producing bisindolymalimides
ZA972080B (en) Process for producing cephalosporin antibiotics.
AU1626197A (en) Process for producing cephalosporin antibiotics
IL122454A0 (en) Process for forming bubble-pack
HUP9701013A3 (en) Process for producing cephem-and isooxacephem derivatives
AU4958397A (en) Process for making benzisothiazolin-3-ones
AU5035198A (en) Novel beta-lactam compounds and process for preparing the same
GB2310853B (en) Process for producing tetrafluoromethane
EP0794002A3 (en) Process for producing mixed-cation zeolites
AU3953297A (en) Process for preparing paclitaxel
AU4115897A (en) Process for preparing 6-aminocapronitrile
GB9810888D0 (en) Process for synthesizing carbapenem antibiotics
AU4724797A (en) Novel process for preparing fr900482 and compounds analogous thereto
AU4014597A (en) Process for producing eltanolone
HUP9903016A3 (en) Improved process for synthesizing carbapenem intermediates
GB9617417D0 (en) Process for synthesizing carbapenem antibodies
AU5191898A (en) Novel phosphinopyrrolidine compounds and process for producing the same
AU5485596A (en) Process for making 1-hydroxybisphosphonates
GB9602921D0 (en) Improved process for synthesizing carbapenem intermediates

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140708